Cerebral and Pulse Oximeter Global Market - Forecast to 2026
Cerebral and pulse oximeters are class of non-invasive medical devices used for monitoring of oxygen saturation in arterial and cerebral blood. These devices are mainly used for monitoring purposes in critical care, Operation rooms, general wards, home care settings, ambulatory surgical centers and in recreational activities where continuous monitoring of oxygen is required. Variation in oxygen level may leads to several complications such as hypoxia, Polycythemia, which is an increased production of red blood cells. Polycythemia increases the risk of clotting and can hurt brain function. Hence to prevent brain damage, heart failure and death continuous monitoring of oxygen level in blood is needed.
Cerebral and pulse oximeter global market is segmented on the basis of products, applications, end-users and geography. The products market is segmented into cerebral oximeter and pulse oximeter, among them pulse oximeter segment held the largest share of the market with xx% in 2019 and are expected to grow at a low single digit CAGR of %xx from 2019 to 2026 and Cerebral oximeter segment is expected to grow at a mid single digit CAGR of xx% from 2019 to 2026. Pulse oximeters are further sub-segmented into Fingertip, handheld, table top and other pulse oximeters. The handheld pulse oximeter accounted for the largest share of xx% in 2019 and is expected to grow at a low single digit CAGR of xx% from 2019 to 2026. Fingertip pulse oximeter is expected to grow at a low single digit CAGR of xx% from 2019 to 2026. Based on the products, pulse oximeters are further segmented into monitors and sensors. Among these, pulse oximeter sensors segment accounted for the largest share of xx% in 2019 and is expected to grow at a strong CAGR of xx% from 2019 to 2026. Pulse oximeter sensors are further segmented into reusable and disposable sensors, reusable sensors segment accounted for the largest share of xx% in 2019 and is expected to grow at a low single digit CAGR of xx% from 2019 to 2026. Cerebral oximeters are segmented into cerebral oximeter monitor and cerebral oximeter sensors, among these cerebral oximeter sensors segment accounted for the largest share of xx% in 2019 and is expected to grow at a mid single digit CAGR of xx% from 2019 to 2026. Cerebral oximeter sensors are further segmented into single emitter dual detector, dual emitter dual detector, four emitter dual detector, five emitter dual detector and others. Among these, single emitter dual detector accounted for the largest share of xx% in 2019 and is expected to grow at a mid single digit CAGR of x% from 2019 to 2026. Five emitter dual detectors segment is expected to grow at a mid single digit CAGR of xx% from 2019 to 2026.
Applications are segmented into monitoring and surgeries, among them, monitoring segment held the largest share of xx% in 2019 and is expected to grow at a low single digit CAGR of xx% from 2019 to 2026. Surgeries segment is expected to be the fastest growing segment with mid single digit CAGR xx% from 2019 to 2026.
End-users are classified into hospitals, ambulatory surgical centers, home healthcare and others. Among them, hospitals segment commanded the largest segmental share of xx% in 2019 and is expected to be the fastest growing segment with a low single digit CAGR of xx% from 2019 to 2026. Hospitals are further segmented into operation theater, ICU, general ward and others, General ward was the largest segment commanding a share of xx% in 2019 and is expected to grow at a low single digit CAGR of xx% from 2019 to 2026. Operation room segment is expected to grow at a strong mid single digit CAGR of xx% from 2019 to 2026.
Geographically, North America is the largest market, with a share of xx% followed by Europe and Asia Pacific. The APAC region is the fastest growing region and is expected to grow at a mid single digit CAGR of xx% from 2019 to 2026 presenting an array of opportunities for growth and is likely to get the attention of new investors in the cerebral and pulse oximeter market. Growth in the Asian market is attributed to rising prevalence of respiratory disorders and government initiatives in establishing innovative technologies and demand for sophisticated medical services.
The cerebral and pulse oximeter are expected to grow steadily at a low single digit CAGR of xx% from 2019 to 2026. Increase in incidence of respiratory and cardiovascular diseases, rising adoption in homecare settings, growing use of patient monitoring devices in hospitals and launch of convenient fingertip and wrist oximeters are the factors driving the market growth. The technological advancements and increase in new product approval are expected to offer potential opportunities.
However, various factors such as inaccuracy in results, skin integrity issues are limiting the growth of cerebral and pulse oximeter global market. The threats for the market include lack of awareness about the diseases in emerging countries and stringent regulatory requirements for new products.
The cerebral and pulse oximeter global market is a highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Major players in cerebral and pulse oximeter market include Masimo Corporation (Switzerland), Medtronic PLC. (Ireland), Koninklijke Philips N.V. (Netherlands), GE healthcare (U.S.), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Nihon Kohden (Japan), Smiths Medical (U.S.), Nonin Medical Inc. (U.S.), Edwards Lifesciences Corporation (U.S.), RossMax International Inc. (U.S.) and Heal Force Bio-meditech Holdings Limited (China).
The report provides an in-depth market analysis of the above-mentioned segments across the following regions:
Cerebral and pulse oximeter global market is segmented on the basis of products, applications, end-users and geography. The products market is segmented into cerebral oximeter and pulse oximeter, among them pulse oximeter segment held the largest share of the market with xx% in 2019 and are expected to grow at a low single digit CAGR of %xx from 2019 to 2026 and Cerebral oximeter segment is expected to grow at a mid single digit CAGR of xx% from 2019 to 2026. Pulse oximeters are further sub-segmented into Fingertip, handheld, table top and other pulse oximeters. The handheld pulse oximeter accounted for the largest share of xx% in 2019 and is expected to grow at a low single digit CAGR of xx% from 2019 to 2026. Fingertip pulse oximeter is expected to grow at a low single digit CAGR of xx% from 2019 to 2026. Based on the products, pulse oximeters are further segmented into monitors and sensors. Among these, pulse oximeter sensors segment accounted for the largest share of xx% in 2019 and is expected to grow at a strong CAGR of xx% from 2019 to 2026. Pulse oximeter sensors are further segmented into reusable and disposable sensors, reusable sensors segment accounted for the largest share of xx% in 2019 and is expected to grow at a low single digit CAGR of xx% from 2019 to 2026. Cerebral oximeters are segmented into cerebral oximeter monitor and cerebral oximeter sensors, among these cerebral oximeter sensors segment accounted for the largest share of xx% in 2019 and is expected to grow at a mid single digit CAGR of xx% from 2019 to 2026. Cerebral oximeter sensors are further segmented into single emitter dual detector, dual emitter dual detector, four emitter dual detector, five emitter dual detector and others. Among these, single emitter dual detector accounted for the largest share of xx% in 2019 and is expected to grow at a mid single digit CAGR of x% from 2019 to 2026. Five emitter dual detectors segment is expected to grow at a mid single digit CAGR of xx% from 2019 to 2026.
Applications are segmented into monitoring and surgeries, among them, monitoring segment held the largest share of xx% in 2019 and is expected to grow at a low single digit CAGR of xx% from 2019 to 2026. Surgeries segment is expected to be the fastest growing segment with mid single digit CAGR xx% from 2019 to 2026.
End-users are classified into hospitals, ambulatory surgical centers, home healthcare and others. Among them, hospitals segment commanded the largest segmental share of xx% in 2019 and is expected to be the fastest growing segment with a low single digit CAGR of xx% from 2019 to 2026. Hospitals are further segmented into operation theater, ICU, general ward and others, General ward was the largest segment commanding a share of xx% in 2019 and is expected to grow at a low single digit CAGR of xx% from 2019 to 2026. Operation room segment is expected to grow at a strong mid single digit CAGR of xx% from 2019 to 2026.
Geographically, North America is the largest market, with a share of xx% followed by Europe and Asia Pacific. The APAC region is the fastest growing region and is expected to grow at a mid single digit CAGR of xx% from 2019 to 2026 presenting an array of opportunities for growth and is likely to get the attention of new investors in the cerebral and pulse oximeter market. Growth in the Asian market is attributed to rising prevalence of respiratory disorders and government initiatives in establishing innovative technologies and demand for sophisticated medical services.
The cerebral and pulse oximeter are expected to grow steadily at a low single digit CAGR of xx% from 2019 to 2026. Increase in incidence of respiratory and cardiovascular diseases, rising adoption in homecare settings, growing use of patient monitoring devices in hospitals and launch of convenient fingertip and wrist oximeters are the factors driving the market growth. The technological advancements and increase in new product approval are expected to offer potential opportunities.
However, various factors such as inaccuracy in results, skin integrity issues are limiting the growth of cerebral and pulse oximeter global market. The threats for the market include lack of awareness about the diseases in emerging countries and stringent regulatory requirements for new products.
The cerebral and pulse oximeter global market is a highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Major players in cerebral and pulse oximeter market include Masimo Corporation (Switzerland), Medtronic PLC. (Ireland), Koninklijke Philips N.V. (Netherlands), GE healthcare (U.S.), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Nihon Kohden (Japan), Smiths Medical (U.S.), Nonin Medical Inc. (U.S.), Edwards Lifesciences Corporation (U.S.), RossMax International Inc. (U.S.) and Heal Force Bio-meditech Holdings Limited (China).
The report provides an in-depth market analysis of the above-mentioned segments across the following regions:
- North America
- U.S.
- Rest of North America
- Europe
- Germany
- Italy
- France
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Rest of APAC
- Rest of the World (RoW)
- Brazil
- Rest of Latin America
- Middle East and Others
1 EXECUTIVE SUMMARY
2 INTRODUCTION
2.1 KEY TAKEAWAYS
2.2 SCOPE OF THE REPORT
2.3 REPORT DESCRIPTION
2.4 MARKETS COVERED
2.5 STAKEHOLDERS
2.6 RESEARCH METHODOLOGY
2.6.1 MARKET SIZE ESTIMATION
2.6.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.6.3 SECONDARY SOURCES
2.6.4 PRIMARY SOURCES
2.6.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.6.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.6.7 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.3.1 DRIVERS AND OPPORTUNITIES
3.3.1.1 Increase in incidence of cardiac and respiratory disorders
3.3.1.2 Technological advancements
3.3.1.3 Increase in hospitalization and surgeries
3.3.1.4 Increase in demand for pulse oximeters in homecare settings and recreational activities.
3.3.2 RESTRAINTS AND THREATS
3.3.2.1 Inaccuracy of results
3.3.2.2 Skin integrity issues
3.3.2.3 Lack of awareness of the disease
3.3.2.4 Stringent regulatory requirements for new products
3.4 REGULATORY AFFAIRS
3.4.1 INTERNATIONAL ORGANIZATION FOR STANDARDIZATION
3.4.1.1 ISO 9001: 2015 Quality Management System
3.4.1.2 ISO 13485 Medical Devices
3.4.2 U.S.
3.4.3 CANADA
3.4.4 EUROPE
3.4.5 INDIA
3.4.6 CHINA
3.4.7 JAPAN
3.5 TECHNOLOGICAL ADVANCEMENTS
3.5.1 INTRODUCTION
3.5.2 HIGH RESOLUTION PULSE OXIMETRY
3.5.3 ORGANIC LED’S IN PULSE OXIMETER
3.5.4 PULSE OXIMETERS PREVENTION OF RESPIRATORY ARREST AND DEATH DUE TO OPIOIDS OVERDOSE
3.5.5 RETINAL OXIMETRY
3.6 PORTER’S FIVE FORCE ANALYSIS
3.6.1 THREAT OF NEW ENTRANTS
3.6.2 THREAT OF SUBSTITUTES
3.6.3 RIVALRY AMONG EXISTING COMPETITORS
3.6.4 BARGAINING POWER OF SUPPLIERS
3.6.5 BARGAINING POWER OF BUYERS
3.7 SUPPLY CHAIN ANALYSIS
3.8 MARKET SHARE ANALYSIS
3.8.1 CEREBRAL AND PULSE OXIMETER GLOBAL MARKET SHARE ANALYSIS
3.8.2 CEREBRAL OXIMETER MARKET SHARE ANALYSIS
3.8.3 PULSE OXIMETER MARKET SHARE ANALYSIS
3.8.4 FINGERTIP MARKET SHARE ANALYSIS
3.8.5 HANDHELD MARKET SHARE ANALYSIS
3.8.6 TABLETOP MARKET SHARE ANALYSIS
3.8.7 OTHERS MARKET SHARE ANALYSIS
3.9 OXIMETER PRODUCT APPROVALS
3.10 REIMBURSEMENT SCENARIO
3.11 ADULT V/S NEONATAL/PEDIATRIC CEREBRAL AND PULSE OXIMETER
3.12 CEREBRAL OXIMETR UNITS SOLD AND INSTALLED BASE AND MARKET PENETRATION
3.12.1 CEREBRAL OXIMETER UNITS SOLD AND INSTALLED BASE BY END-USER
3.13 PULSE OXIMETERS UNITS SOLD AND INSTALLED BASE
3.13.1 PULSE OXIMETER UNITS SOLD AND INSTALLED BASE BY END-USER
4 CEREBRAL AND PULSE OXIMETER GLOBAL MARKET, BY PRODUCT
4.1 INTRODUCTION
4.2 CEREBRAL OXIMETER
4.2.1 CEREBRAL OXIMETER MONITOR
4.2.2 CEREBRAL OXIMETER SENSORS
4.2.2.1 Single emitter dual detector
4.2.2.2 Dual emitter dual detector
4.2.2.3 Four emitter dual detector
4.2.2.4 Five emitter dual detector
4.2.2.5 Other sensors
4.3 PULSE OXIMETER
4.3.1 PULSE OXIMETER DEVICES
4.3.1.1 Fingertip pulse oximeters
4.3.1.2 Handheld pulse oximeters
4.3.1.3 Tabletop pulse oximeters
4.3.1.4 Others
4.3.2 PULSE OXIMETER BY PRODUCTS
4.3.2.1 Pulse oximeter monitors
4.3.2.2 Pulse oximeter sensors
4.3.2.2.1 Reusable sensors
4.3.2.2.2 Disposable sensors
5 CEREBRAL AND PULSE OXIMETER GLOBAL MARKET, BY APPLICATION
5.1 INTRODUCTION
5.2 SURGERIES
5.3 MONITORING
6 CEREBRAL AND PULSE OXIMETER GLOBAL MARKET, BY END-USERS
6.1 INTRODUCTION
6.2 HOSPITALS
6.2.1 OPERATION ROOMS
6.2.2 INTENSIVE CARE UNIT
6.2.2.1 Neonatal intensive care unit
6.2.2.2 Adult intensive care unit
6.2.3 GENERAL WARDS
6.2.4 OTHER HOSPITAL CARE SETTINGS
6.3 AMBULATORY SURGICAL CENTERS
6.4 HOME HEALTHCARE
6.5 OTHERS (SLEEP CENTERS, RECREATIONAL ACTIVITIES, CLINICS/PHYSICIAN OFFICES, HOSPICES)
7 CEREBRAL AND PULSE OXIMETER MARKET BY REGION
7.1 INTRODUCTION
7.2 NORTH AMERICA
7.2.1 U.S.
7.2.2 REST OF NORTH AMERICA
7.3 EUROPE
7.3.1 GERMANY
7.3.2 FRANCE
7.3.3 ITALY
7.3.4 REST OF EUROPE
7.4 APAC
7.4.1 JAPAN
7.4.2 CHINA
7.4.3 INDIA
7.4.4 REST OF APAC
7.5 ROW
7.5.1 BRAZIL
7.5.2 REST OF LATAM
7.5.3 MIDDLE EAST AND OTHERS
8 COMPETITIVE LANDSCAPE
8.1 INTRODUCTION
8.2 APPROVALS
8.3 AGREEMENTS
8.4 ACQUISITION
9 MAJOR COMPANIES
9.1 EDWARDS LIFESCIENCES CORPORATION.
9.1.1 OVERVIEW
9.1.2 FINANCIALS
9.1.3 PRODUCT PORTFOLIO
9.1.4 KEY DEVELOPMENTS
9.1.5 BUSINESS STRATEGY
9.1.6 SWOT ANALYSIS
9.2 GE HEALTHCARE
9.2.1 OVERVIEW
9.2.2 FINANCIALS
9.2.3 PRODUCT PORTFOLIO
9.2.4 KEY DEVELOPMENTS
9.2.5 BUSINESS STRATEGY
9.2.6 SWOT ANALYSIS
9.3 HEAL-FORCE BIO-MEDITECH HOLDINGS LIMITED.
9.3.1 OVERVIEW
9.3.2 FINANCIALS
9.3.3 PRODUCT PORTFOLIO
9.3.4 KEY DEVELOPMENTS
9.3.5 BUSINESS STRATEGY
9.3.6 SWOT ANALYSIS
9.4 KONINKLIJKE PHILIPS N.V.
9.4.1 OVERVIEW
9.4.3 PRODUCT PORTFOLIO
9.4.4 KEY DEVELOPMENTS
9.4.5 BUSINESS STRATEGY
9.4.6 SWOT ANALYSIS
9.5 MASIMO CORPORATION
9.5.1 OVERVIEW
9.5.2 FINANCIALS
9.5.3 PRODUCT PORTFOLIO
9.5.4 KEY DEVELOPMENTS
9.5.5 BUSINESS STRATEGY
9.5.6 SWOT ANALYSIS
9.6 MEDTRONIC PLC
9.6.1 OVERVIEW
9.6.2 FINANCIALS
9.6.3 PRODUCT PORTFOLIO
9.6.4 KEY DEVELOPMENTS
9.6.5 BUSINESS STRATEGY
9.6.6 SWOT ANALYSIS
9.7 NIHON KOHEDEN CORPORATION.
9.7.1 OVERVIEW
9.7.2 FINANCIALS
9.7.3 PRODUCT PORTFOLIO
9.7.4 KEY DEVELOPMENTS
9.7.5 BUSINESS STRATEGY
9.7.6 SWOT ANALYSIS
9.8 NONIN MEDICAL INC.
9.8.1 OVERVIEW
9.8.2 FINANCIALS
9.8.3 PRODUCT PORTFOLIO
9.8.4 KEY DEVELOPMENTS
9.8.5 BUSINESS STRATEGY
9.8.6 SWOT ANALYSIS
9.9 ROSSMAX INTERNATIONAL LTD.
9.9.1 OVERVIEW
9.9.2 FINANCIALS
9.9.3 PRODUCT PORTFOLIO
9.9.4 KEY DEVELOPMENTS
9.9.5 BUSINESS STRATEGY
9.9.6 SWOT ANALYSIS
9.10 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONIC CO., LTD.
9.10.1 OVERVIEW
9.10.2 FINANCIALS
9.10.3 PRODUCT PORTFOLIO
9.10.4 KEY DEVELOPMENTS
9.10.5 BUSINESS STRATEGY
9.10.6 SWOT ANALYSIS
9.11 SMITHS MEDICAL
9.11.1 OVERVIEW
9.11.2 FINANCIALS
9.11.3 PRODUCT PORTFOLIO
9.11.4 KEY DEVELOPMENTS
9.11.5 BUSINESS STRATEGY
9.11.6 SWOT ANALYSIS
2 INTRODUCTION
2.1 KEY TAKEAWAYS
2.2 SCOPE OF THE REPORT
2.3 REPORT DESCRIPTION
2.4 MARKETS COVERED
2.5 STAKEHOLDERS
2.6 RESEARCH METHODOLOGY
2.6.1 MARKET SIZE ESTIMATION
2.6.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.6.3 SECONDARY SOURCES
2.6.4 PRIMARY SOURCES
2.6.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.6.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.6.7 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.3.1 DRIVERS AND OPPORTUNITIES
3.3.1.1 Increase in incidence of cardiac and respiratory disorders
3.3.1.2 Technological advancements
3.3.1.3 Increase in hospitalization and surgeries
3.3.1.4 Increase in demand for pulse oximeters in homecare settings and recreational activities.
3.3.2 RESTRAINTS AND THREATS
3.3.2.1 Inaccuracy of results
3.3.2.2 Skin integrity issues
3.3.2.3 Lack of awareness of the disease
3.3.2.4 Stringent regulatory requirements for new products
3.4 REGULATORY AFFAIRS
3.4.1 INTERNATIONAL ORGANIZATION FOR STANDARDIZATION
3.4.1.1 ISO 9001: 2015 Quality Management System
3.4.1.2 ISO 13485 Medical Devices
3.4.2 U.S.
3.4.3 CANADA
3.4.4 EUROPE
3.4.5 INDIA
3.4.6 CHINA
3.4.7 JAPAN
3.5 TECHNOLOGICAL ADVANCEMENTS
3.5.1 INTRODUCTION
3.5.2 HIGH RESOLUTION PULSE OXIMETRY
3.5.3 ORGANIC LED’S IN PULSE OXIMETER
3.5.4 PULSE OXIMETERS PREVENTION OF RESPIRATORY ARREST AND DEATH DUE TO OPIOIDS OVERDOSE
3.5.5 RETINAL OXIMETRY
3.6 PORTER’S FIVE FORCE ANALYSIS
3.6.1 THREAT OF NEW ENTRANTS
3.6.2 THREAT OF SUBSTITUTES
3.6.3 RIVALRY AMONG EXISTING COMPETITORS
3.6.4 BARGAINING POWER OF SUPPLIERS
3.6.5 BARGAINING POWER OF BUYERS
3.7 SUPPLY CHAIN ANALYSIS
3.8 MARKET SHARE ANALYSIS
3.8.1 CEREBRAL AND PULSE OXIMETER GLOBAL MARKET SHARE ANALYSIS
3.8.2 CEREBRAL OXIMETER MARKET SHARE ANALYSIS
3.8.3 PULSE OXIMETER MARKET SHARE ANALYSIS
3.8.4 FINGERTIP MARKET SHARE ANALYSIS
3.8.5 HANDHELD MARKET SHARE ANALYSIS
3.8.6 TABLETOP MARKET SHARE ANALYSIS
3.8.7 OTHERS MARKET SHARE ANALYSIS
3.9 OXIMETER PRODUCT APPROVALS
3.10 REIMBURSEMENT SCENARIO
3.11 ADULT V/S NEONATAL/PEDIATRIC CEREBRAL AND PULSE OXIMETER
3.12 CEREBRAL OXIMETR UNITS SOLD AND INSTALLED BASE AND MARKET PENETRATION
3.12.1 CEREBRAL OXIMETER UNITS SOLD AND INSTALLED BASE BY END-USER
3.13 PULSE OXIMETERS UNITS SOLD AND INSTALLED BASE
3.13.1 PULSE OXIMETER UNITS SOLD AND INSTALLED BASE BY END-USER
4 CEREBRAL AND PULSE OXIMETER GLOBAL MARKET, BY PRODUCT
4.1 INTRODUCTION
4.2 CEREBRAL OXIMETER
4.2.1 CEREBRAL OXIMETER MONITOR
4.2.2 CEREBRAL OXIMETER SENSORS
4.2.2.1 Single emitter dual detector
4.2.2.2 Dual emitter dual detector
4.2.2.3 Four emitter dual detector
4.2.2.4 Five emitter dual detector
4.2.2.5 Other sensors
4.3 PULSE OXIMETER
4.3.1 PULSE OXIMETER DEVICES
4.3.1.1 Fingertip pulse oximeters
4.3.1.2 Handheld pulse oximeters
4.3.1.3 Tabletop pulse oximeters
4.3.1.4 Others
4.3.2 PULSE OXIMETER BY PRODUCTS
4.3.2.1 Pulse oximeter monitors
4.3.2.2 Pulse oximeter sensors
4.3.2.2.1 Reusable sensors
4.3.2.2.2 Disposable sensors
5 CEREBRAL AND PULSE OXIMETER GLOBAL MARKET, BY APPLICATION
5.1 INTRODUCTION
5.2 SURGERIES
5.3 MONITORING
6 CEREBRAL AND PULSE OXIMETER GLOBAL MARKET, BY END-USERS
6.1 INTRODUCTION
6.2 HOSPITALS
6.2.1 OPERATION ROOMS
6.2.2 INTENSIVE CARE UNIT
6.2.2.1 Neonatal intensive care unit
6.2.2.2 Adult intensive care unit
6.2.3 GENERAL WARDS
6.2.4 OTHER HOSPITAL CARE SETTINGS
6.3 AMBULATORY SURGICAL CENTERS
6.4 HOME HEALTHCARE
6.5 OTHERS (SLEEP CENTERS, RECREATIONAL ACTIVITIES, CLINICS/PHYSICIAN OFFICES, HOSPICES)
7 CEREBRAL AND PULSE OXIMETER MARKET BY REGION
7.1 INTRODUCTION
7.2 NORTH AMERICA
7.2.1 U.S.
7.2.2 REST OF NORTH AMERICA
7.3 EUROPE
7.3.1 GERMANY
7.3.2 FRANCE
7.3.3 ITALY
7.3.4 REST OF EUROPE
7.4 APAC
7.4.1 JAPAN
7.4.2 CHINA
7.4.3 INDIA
7.4.4 REST OF APAC
7.5 ROW
7.5.1 BRAZIL
7.5.2 REST OF LATAM
7.5.3 MIDDLE EAST AND OTHERS
8 COMPETITIVE LANDSCAPE
8.1 INTRODUCTION
8.2 APPROVALS
8.3 AGREEMENTS
8.4 ACQUISITION
9 MAJOR COMPANIES
9.1 EDWARDS LIFESCIENCES CORPORATION.
9.1.1 OVERVIEW
9.1.2 FINANCIALS
9.1.3 PRODUCT PORTFOLIO
9.1.4 KEY DEVELOPMENTS
9.1.5 BUSINESS STRATEGY
9.1.6 SWOT ANALYSIS
9.2 GE HEALTHCARE
9.2.1 OVERVIEW
9.2.2 FINANCIALS
9.2.3 PRODUCT PORTFOLIO
9.2.4 KEY DEVELOPMENTS
9.2.5 BUSINESS STRATEGY
9.2.6 SWOT ANALYSIS
9.3 HEAL-FORCE BIO-MEDITECH HOLDINGS LIMITED.
9.3.1 OVERVIEW
9.3.2 FINANCIALS
9.3.3 PRODUCT PORTFOLIO
9.3.4 KEY DEVELOPMENTS
9.3.5 BUSINESS STRATEGY
9.3.6 SWOT ANALYSIS
9.4 KONINKLIJKE PHILIPS N.V.
9.4.1 OVERVIEW
9.4.3 PRODUCT PORTFOLIO
9.4.4 KEY DEVELOPMENTS
9.4.5 BUSINESS STRATEGY
9.4.6 SWOT ANALYSIS
9.5 MASIMO CORPORATION
9.5.1 OVERVIEW
9.5.2 FINANCIALS
9.5.3 PRODUCT PORTFOLIO
9.5.4 KEY DEVELOPMENTS
9.5.5 BUSINESS STRATEGY
9.5.6 SWOT ANALYSIS
9.6 MEDTRONIC PLC
9.6.1 OVERVIEW
9.6.2 FINANCIALS
9.6.3 PRODUCT PORTFOLIO
9.6.4 KEY DEVELOPMENTS
9.6.5 BUSINESS STRATEGY
9.6.6 SWOT ANALYSIS
9.7 NIHON KOHEDEN CORPORATION.
9.7.1 OVERVIEW
9.7.2 FINANCIALS
9.7.3 PRODUCT PORTFOLIO
9.7.4 KEY DEVELOPMENTS
9.7.5 BUSINESS STRATEGY
9.7.6 SWOT ANALYSIS
9.8 NONIN MEDICAL INC.
9.8.1 OVERVIEW
9.8.2 FINANCIALS
9.8.3 PRODUCT PORTFOLIO
9.8.4 KEY DEVELOPMENTS
9.8.5 BUSINESS STRATEGY
9.8.6 SWOT ANALYSIS
9.9 ROSSMAX INTERNATIONAL LTD.
9.9.1 OVERVIEW
9.9.2 FINANCIALS
9.9.3 PRODUCT PORTFOLIO
9.9.4 KEY DEVELOPMENTS
9.9.5 BUSINESS STRATEGY
9.9.6 SWOT ANALYSIS
9.10 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONIC CO., LTD.
9.10.1 OVERVIEW
9.10.2 FINANCIALS
9.10.3 PRODUCT PORTFOLIO
9.10.4 KEY DEVELOPMENTS
9.10.5 BUSINESS STRATEGY
9.10.6 SWOT ANALYSIS
9.11 SMITHS MEDICAL
9.11.1 OVERVIEW
9.11.2 FINANCIALS
9.11.3 PRODUCT PORTFOLIO
9.11.4 KEY DEVELOPMENTS
9.11.5 BUSINESS STRATEGY
9.11.6 SWOT ANALYSIS
LIST OF TABLES
TABLE 1 CEREBRAL AND PULSE OXIMETER GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 2 CEREBRAL AND PULSE OXIMETER GLOBAL MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 3 CEREBRAL OXIMETER GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2018-2026) ($MN)
TABLE 4 CEREBRAL OXIMETER MONITOR GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 5 CEREBRAL OXIMETER SENOSRS GLOBAL MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 6 SINGLE EMITTER DUAL DETECTOR GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 7 DUAL EMITTER DUAL DETECTOR GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 8 FOUR EMITTER DUAL DETECTOR GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 9 FIVE EMITTER DUAL DETECTOR GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 10 OTHER SENSORS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 11 PULSE OXIMETER DEVICES GLOBAL MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 12 PULSE OXIMETER GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 13 FINGERTIP PULSE OXIMETER GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 14 HANDHELD PULSE OXIMETER GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 15 TABLETOP PULSE OXIMETER GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 16 OTHER PULSE OXIMETER GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 17 PULSE OXIMETER GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2018-2026) ($MN)
TABLE 18 PULSE OXIMETER MONITOR GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 19 PULSE OXIMETER SENSORS GLOBAL MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 20 PULSE OXIMETER SENSORS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 21 REUSABLE SENSORS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 22 DISPOSABLE SENSORS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 23 CEREBRAL AND PULSE OXIMETER GLOBAL MARKET REVENUE, BY APLLICATION, (2018-2026) ($MN)
TABLE 24 SURGERIES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 25 MONITORING GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 26 CEREBRAL AND PULSE OXIMETER GLOBAL MARKET REVENUE, BY END-USERS, (2018-2026) ($MN)
TABLE 27 HOSPITAL GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 28 HOSPITALS GLOBAL MARKET REVENUE, BY SITE OF CARE, (2018-2026) ($MN)
TABLE 29 OPERATION ROOMS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 30 INTENSIVE CARE UNIT GLOBAL MARKET REVENUE, BY SITE OF CARE, (2018-2026) ($MN)
TABLE 31 ICU GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 32 NICU GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 33 ADULT ICU GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 34 GENERAL WARD GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 35 OTHER HOSPITAL CARE SETTINGS GLOBAL MARKET REVENUE BY REGION, (2018-2026) ($MN)
TABLE 36 AMBULATORY SURGICAL CENTERS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 37 HOME HEALTHCARE GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 38 OTHER END-USER GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 39 CEREBRAL AND PULSE OXIMETER GLOBAL MARKETREVENUE, BY REGION, (2018-2026) ($MN)
TABLE 40 NORTH AMERICA CEREBRAL AND PULSE OXIMETER MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 41 NORTH AMERICA CEREBRAL OXIMETER MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 42 NORTH AMERICA CEREBRAL OXIMETER SENSORS MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 43 NORTH AMERICA PULSE OXIMETER MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 44 NORTH AMERICA PULSE OXIMETER MARKET REVENUE, BY PRODUCT TYPE, (2018-2026) ($MN)
TABLE 45 NORTH AMERICA PULSE OXIMETER SENSORS MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 46 NORTH AMERICA CEREBRAL AND PULSE OXIMETER MARKET REVENUE, BY APPLICATION, (2018-2026) ($MN)
TABLE 47 NORTH AMERICA CEREBRAL AND PULSE OXIMETER MARKET REVENUE, BY END-USER, (2018-2026) ($MN)
TABLE 48 NORTH AMERICA HOSPITAL MARKET REVENUE BY SITE OF CARE, (2018-2026) ($MN)
TABLE 49 NORTH AMERICA ICU MARKET REVENUE BY SITE OF CARE, (2018-2026) ($MN)
TABLE 50 NORTH AMERICA CEREBRAL AND PULSE OXIMETER MARKET REVENUE, BY COUNTRY, (2018-2026) ($MN)
TABLE 51 EUROPE CEREBRAL AND PULSE OXIMETER MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 52 EUROPE CEREBRAL OXIMETER MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 53 EUROPE CEREBRAL OXIMETER SENSORS MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 54 EUROPE PULSE OXIMETER MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 55 EUROPE PULSE OXIMETER MARKET REVENUE, BY PRODUCT TYPE, (2018-2026) ($MN)
TABLE 56 EUROPE PULSE OXIMETER SENSORS MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 57 EUROPE CEREBRAL AND PULSE OXIMETER MARKET REVENUE, BY APPLICATION, (2018-2026) ($MN)
TABLE 58 EUROPE CEREBRAL AND PULSE OXIMETER MARKET REVENUE, BY END-USER, (2018-2026) ($MN)
TABLE 59 EUROPE HOSPITAL MARKET REVENUE BY SITE OF CARE, (2018-2026) ($MN)
TABLE 60 EUROPE ICU MARKET REVENUE BY SITE OF CARE, (2018-2026) ($MN)
TABLE 61 EUROPE CEREBRAL AND PULSE OXIMETER MARKET REVENUE BY COUNTRY, (2018-2026) ($MN)
TABLE 62 APAC CEREBRAL AND PULSE OXIMETER MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 63 APAC CEREBRAL OXIMETER MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 64 APAC CEREBRAL OXIMETER SENSORS MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 65 APAC PULSE OXIMETER MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 66 APAC PULSE OXIMETER MARKET REVENUE, BY PRODUCT TYPE, (2018-2026) ($MN)
TABLE 67 APAC PULSE OXIMETER SENSORS MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 68 APAC CEREBRAL AND PULSE OXIMETER MARKET REVENUE, BY APPLICATION, (2018-2026) ($MN)
TABLE 69 APAC CEREBRAL AND PULSE OXIMETER MARKET REVENUE, BY END-USER, (2018-2026) ($MN)
TABLE 70 APAC HOSPITALS MARKET REVENUE BY SITE OF CARE, (2018-2026) ($MN)
TABLE 71 APAC ICU MARKET REVENUE BY SITE OF CARE, (2018-2026) ($MN)
TABLE 72 APAC CEREBRAL AND PULSE OXIMETER MARKET REVENUE, BY COUNTRY, (2018-2026) ($MN)
TABLE 73 ROW CEREBRAL AND PULSE OXIMETER MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 74 ROW CEREBRAL OXIMETER MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 75 ROW CEREBRAL OXIMETER SENSORS MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 76 ROW PULSE OXIMETER MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 77 ROW PULSE OXIMETER MARKET REVENUE, BY PRODUCT TYPE, (2018-2026) ($MN)
TABLE 78 ROW PULSE OXIMETER SENSORS MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 79 ROW CEREBRAL AND PULSE OXIMETER MARKET REVENUE, BY APPLICATION, (2018-2026) ($MN)
TABLE 80 ROW CEREBRAL AND PULSE OXIMETER MARKET REVENUE, BY END-USER, (2018-2026) ($MN)
TABLE 81 ROW HOSPITALS MARKET REVENUE BY SITE OF CARE, (2018-2026) ($MN)
TABLE 82 ROW ICU MARKET REVENUE BY SITE OF CARE, (2018-2026) ($MN)
TABLE 83 ROW CEREBRAL AND PULSE OXIMETER MARKET REVENUE, BY COUNTRY, (2018-2026) ($MN)
TABLE 84 APPROVALS (2018-2019)
TABLE 85 AGREEMENTS (2018-2019)
TABLE 86 ACQUISITION (2018-2019)
TABLE 87 EDWARDS LIFESCIENCES CORPORATION: TOTAL REVENUE AND R&D EXPENSES (2017-2019) (Q3) ($MN)
TABLE 88 EDWARDS LIFESCIENCES CORPORATION: TOTAL REVENUE, BY BUSINESS SEGMENTS (2017-2019) (Q3) ($MN)
TABLE 89 EDWARDS LIFESCIENCES CORPORATION: TOTAL REVENUE, BY GEOGRAPHY (2017-2019) (Q3) ($MN)
TABLE 90 GE COMPANY: TOTAL REVENUE AND R&D EXPENSES (2017 – 2019) (Q3) ($MN)
TABLE 91 GE COMPANY: TOTAL REVENUE, BY SEGMENTS (2017-2019) (Q3) ($MN)
TABLE 92 GE COMPANY: TOTAL REVENUE, BY HEALTHCARE SEGMENT (2017 –2019) (Q3) ($MN)
TABLE 93 GE COMPANY: TOTAL REVENUE, BY GEOGRAPHY (2017 –2019) (Q3) ($MN)
TABLE 94 KONINKLIJKE PHILIPS N.V.: TOTAL REVENUE AND R&D EXPENSES (2017 - 2019) (Q3) ($MN)
TABLE 95 KONINKLIJKE PHILIPS N.V.: TOTAL REVENUE, BY SEGMENTS (2017-2019) (Q3) ($MN)
TABLE 96 KONINKLIJKE PHILIPS N.V.: TOTAL REVENUE, BY GEOGRAPHY (2017 –2019) (Q3) ($MN)
TABLE 97 MASIMO CORPORATION: TOTAL REVENUE AND R&D EXPENSES (2017-2019) (Q3) ($MN)
TABLE 98 MASIMO CORPORATION: TOTAL REVENUE, BY REGIONS (2017-2019) (Q3) ($MN)
TABLE 99 MEDTRONIC PLC: TOTAL REVENUE AND R&D EXPENSES (2017-2019) (Q2) ($MN)
TABLE 100 MEDTRONIC PLC: TOTAL REVENUE, BY SEGMENTS (2017-2019) (Q2) ($MN)
TABLE 101 MEDTRONIC PLC: MINIMALLY INVASIVE THERAPIES GROUP TOTAL REVENUE, BY SUBSEGMENTS (2017-2019) (Q2) ($MN)
TABLE 102 MEDTRONIC PLC: TOTAL REVENUE, BY REGIONS (2017-2019) (Q2) ($MN)
TABLE 103 NIHON KOHDEN: TOTAL REVENUE AND R&D EXPENSES (2017-2019) (Q2) ($MN)
TABLE 104 NIHON KOHDEN: TOTAL REVENUE, BY BUSINESS SEGMENTS (2017-2019) (Q2) ($MN)
TABLE 105 NIHON KOHDEN: TOTAL REVENUE, BY GEOGRAPHY (2017-2019) (Q2) ($MN)
TABLE 106 SMITHS MEDICAL: TOTAL REVENUE AND R&D EXPENSES (2017-2019) ($MN)
TABLE 107 SMITHS MEDICAL: TOTAL REVENUE, BY BUSINESS SEGMENTS (2017-2019) ($MN)
TABLE 1 CEREBRAL AND PULSE OXIMETER GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 2 CEREBRAL AND PULSE OXIMETER GLOBAL MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 3 CEREBRAL OXIMETER GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2018-2026) ($MN)
TABLE 4 CEREBRAL OXIMETER MONITOR GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 5 CEREBRAL OXIMETER SENOSRS GLOBAL MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 6 SINGLE EMITTER DUAL DETECTOR GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 7 DUAL EMITTER DUAL DETECTOR GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 8 FOUR EMITTER DUAL DETECTOR GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 9 FIVE EMITTER DUAL DETECTOR GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 10 OTHER SENSORS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 11 PULSE OXIMETER DEVICES GLOBAL MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 12 PULSE OXIMETER GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 13 FINGERTIP PULSE OXIMETER GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 14 HANDHELD PULSE OXIMETER GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 15 TABLETOP PULSE OXIMETER GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 16 OTHER PULSE OXIMETER GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 17 PULSE OXIMETER GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2018-2026) ($MN)
TABLE 18 PULSE OXIMETER MONITOR GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 19 PULSE OXIMETER SENSORS GLOBAL MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 20 PULSE OXIMETER SENSORS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 21 REUSABLE SENSORS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 22 DISPOSABLE SENSORS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 23 CEREBRAL AND PULSE OXIMETER GLOBAL MARKET REVENUE, BY APLLICATION, (2018-2026) ($MN)
TABLE 24 SURGERIES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 25 MONITORING GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 26 CEREBRAL AND PULSE OXIMETER GLOBAL MARKET REVENUE, BY END-USERS, (2018-2026) ($MN)
TABLE 27 HOSPITAL GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 28 HOSPITALS GLOBAL MARKET REVENUE, BY SITE OF CARE, (2018-2026) ($MN)
TABLE 29 OPERATION ROOMS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 30 INTENSIVE CARE UNIT GLOBAL MARKET REVENUE, BY SITE OF CARE, (2018-2026) ($MN)
TABLE 31 ICU GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 32 NICU GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 33 ADULT ICU GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 34 GENERAL WARD GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 35 OTHER HOSPITAL CARE SETTINGS GLOBAL MARKET REVENUE BY REGION, (2018-2026) ($MN)
TABLE 36 AMBULATORY SURGICAL CENTERS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 37 HOME HEALTHCARE GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 38 OTHER END-USER GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 39 CEREBRAL AND PULSE OXIMETER GLOBAL MARKETREVENUE, BY REGION, (2018-2026) ($MN)
TABLE 40 NORTH AMERICA CEREBRAL AND PULSE OXIMETER MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 41 NORTH AMERICA CEREBRAL OXIMETER MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 42 NORTH AMERICA CEREBRAL OXIMETER SENSORS MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 43 NORTH AMERICA PULSE OXIMETER MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 44 NORTH AMERICA PULSE OXIMETER MARKET REVENUE, BY PRODUCT TYPE, (2018-2026) ($MN)
TABLE 45 NORTH AMERICA PULSE OXIMETER SENSORS MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 46 NORTH AMERICA CEREBRAL AND PULSE OXIMETER MARKET REVENUE, BY APPLICATION, (2018-2026) ($MN)
TABLE 47 NORTH AMERICA CEREBRAL AND PULSE OXIMETER MARKET REVENUE, BY END-USER, (2018-2026) ($MN)
TABLE 48 NORTH AMERICA HOSPITAL MARKET REVENUE BY SITE OF CARE, (2018-2026) ($MN)
TABLE 49 NORTH AMERICA ICU MARKET REVENUE BY SITE OF CARE, (2018-2026) ($MN)
TABLE 50 NORTH AMERICA CEREBRAL AND PULSE OXIMETER MARKET REVENUE, BY COUNTRY, (2018-2026) ($MN)
TABLE 51 EUROPE CEREBRAL AND PULSE OXIMETER MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 52 EUROPE CEREBRAL OXIMETER MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 53 EUROPE CEREBRAL OXIMETER SENSORS MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 54 EUROPE PULSE OXIMETER MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 55 EUROPE PULSE OXIMETER MARKET REVENUE, BY PRODUCT TYPE, (2018-2026) ($MN)
TABLE 56 EUROPE PULSE OXIMETER SENSORS MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 57 EUROPE CEREBRAL AND PULSE OXIMETER MARKET REVENUE, BY APPLICATION, (2018-2026) ($MN)
TABLE 58 EUROPE CEREBRAL AND PULSE OXIMETER MARKET REVENUE, BY END-USER, (2018-2026) ($MN)
TABLE 59 EUROPE HOSPITAL MARKET REVENUE BY SITE OF CARE, (2018-2026) ($MN)
TABLE 60 EUROPE ICU MARKET REVENUE BY SITE OF CARE, (2018-2026) ($MN)
TABLE 61 EUROPE CEREBRAL AND PULSE OXIMETER MARKET REVENUE BY COUNTRY, (2018-2026) ($MN)
TABLE 62 APAC CEREBRAL AND PULSE OXIMETER MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 63 APAC CEREBRAL OXIMETER MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 64 APAC CEREBRAL OXIMETER SENSORS MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 65 APAC PULSE OXIMETER MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 66 APAC PULSE OXIMETER MARKET REVENUE, BY PRODUCT TYPE, (2018-2026) ($MN)
TABLE 67 APAC PULSE OXIMETER SENSORS MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 68 APAC CEREBRAL AND PULSE OXIMETER MARKET REVENUE, BY APPLICATION, (2018-2026) ($MN)
TABLE 69 APAC CEREBRAL AND PULSE OXIMETER MARKET REVENUE, BY END-USER, (2018-2026) ($MN)
TABLE 70 APAC HOSPITALS MARKET REVENUE BY SITE OF CARE, (2018-2026) ($MN)
TABLE 71 APAC ICU MARKET REVENUE BY SITE OF CARE, (2018-2026) ($MN)
TABLE 72 APAC CEREBRAL AND PULSE OXIMETER MARKET REVENUE, BY COUNTRY, (2018-2026) ($MN)
TABLE 73 ROW CEREBRAL AND PULSE OXIMETER MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 74 ROW CEREBRAL OXIMETER MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 75 ROW CEREBRAL OXIMETER SENSORS MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 76 ROW PULSE OXIMETER MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 77 ROW PULSE OXIMETER MARKET REVENUE, BY PRODUCT TYPE, (2018-2026) ($MN)
TABLE 78 ROW PULSE OXIMETER SENSORS MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 79 ROW CEREBRAL AND PULSE OXIMETER MARKET REVENUE, BY APPLICATION, (2018-2026) ($MN)
TABLE 80 ROW CEREBRAL AND PULSE OXIMETER MARKET REVENUE, BY END-USER, (2018-2026) ($MN)
TABLE 81 ROW HOSPITALS MARKET REVENUE BY SITE OF CARE, (2018-2026) ($MN)
TABLE 82 ROW ICU MARKET REVENUE BY SITE OF CARE, (2018-2026) ($MN)
TABLE 83 ROW CEREBRAL AND PULSE OXIMETER MARKET REVENUE, BY COUNTRY, (2018-2026) ($MN)
TABLE 84 APPROVALS (2018-2019)
TABLE 85 AGREEMENTS (2018-2019)
TABLE 86 ACQUISITION (2018-2019)
TABLE 87 EDWARDS LIFESCIENCES CORPORATION: TOTAL REVENUE AND R&D EXPENSES (2017-2019) (Q3) ($MN)
TABLE 88 EDWARDS LIFESCIENCES CORPORATION: TOTAL REVENUE, BY BUSINESS SEGMENTS (2017-2019) (Q3) ($MN)
TABLE 89 EDWARDS LIFESCIENCES CORPORATION: TOTAL REVENUE, BY GEOGRAPHY (2017-2019) (Q3) ($MN)
TABLE 90 GE COMPANY: TOTAL REVENUE AND R&D EXPENSES (2017 – 2019) (Q3) ($MN)
TABLE 91 GE COMPANY: TOTAL REVENUE, BY SEGMENTS (2017-2019) (Q3) ($MN)
TABLE 92 GE COMPANY: TOTAL REVENUE, BY HEALTHCARE SEGMENT (2017 –2019) (Q3) ($MN)
TABLE 93 GE COMPANY: TOTAL REVENUE, BY GEOGRAPHY (2017 –2019) (Q3) ($MN)
TABLE 94 KONINKLIJKE PHILIPS N.V.: TOTAL REVENUE AND R&D EXPENSES (2017 - 2019) (Q3) ($MN)
TABLE 95 KONINKLIJKE PHILIPS N.V.: TOTAL REVENUE, BY SEGMENTS (2017-2019) (Q3) ($MN)
TABLE 96 KONINKLIJKE PHILIPS N.V.: TOTAL REVENUE, BY GEOGRAPHY (2017 –2019) (Q3) ($MN)
TABLE 97 MASIMO CORPORATION: TOTAL REVENUE AND R&D EXPENSES (2017-2019) (Q3) ($MN)
TABLE 98 MASIMO CORPORATION: TOTAL REVENUE, BY REGIONS (2017-2019) (Q3) ($MN)
TABLE 99 MEDTRONIC PLC: TOTAL REVENUE AND R&D EXPENSES (2017-2019) (Q2) ($MN)
TABLE 100 MEDTRONIC PLC: TOTAL REVENUE, BY SEGMENTS (2017-2019) (Q2) ($MN)
TABLE 101 MEDTRONIC PLC: MINIMALLY INVASIVE THERAPIES GROUP TOTAL REVENUE, BY SUBSEGMENTS (2017-2019) (Q2) ($MN)
TABLE 102 MEDTRONIC PLC: TOTAL REVENUE, BY REGIONS (2017-2019) (Q2) ($MN)
TABLE 103 NIHON KOHDEN: TOTAL REVENUE AND R&D EXPENSES (2017-2019) (Q2) ($MN)
TABLE 104 NIHON KOHDEN: TOTAL REVENUE, BY BUSINESS SEGMENTS (2017-2019) (Q2) ($MN)
TABLE 105 NIHON KOHDEN: TOTAL REVENUE, BY GEOGRAPHY (2017-2019) (Q2) ($MN)
TABLE 106 SMITHS MEDICAL: TOTAL REVENUE AND R&D EXPENSES (2017-2019) ($MN)
TABLE 107 SMITHS MEDICAL: TOTAL REVENUE, BY BUSINESS SEGMENTS (2017-2019) ($MN)
LIST OF FIGURES
FIGURE 1 CEREBRAL AND PULSE OXIMETER GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
FIGURE 2 RESEARCH METHODOLOGY: CEREBRAL AND PULSE OXIMETER GLOBAL MARKET
FIGURE 3 CEREBRAL AND PULSE OXIMETER GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
FIGURE 4 CEREBRAL AND PULSE OXIMETER GLOBAL MARKET: FORECASTING MODEL
FIGURE 5 CEREBRAL AND PULSE OXIMETER GLOBAL MARKET: MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 6 CEREBRAL AND PULSE OXIMETER GLOBAL MARKET SEGMENTATION
FIGURE 7 MARKET DYNAMICS
FIGURE 8 CEREBRAL AND PULSE OXIMETER GLOBAL MARKET: PORTER’S ANALYSIS
FIGURE 9 CEREBRAL AND PULSE OXIMETER GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 10 CEREBRAL AND PULSE OXIMETER GLOBAL MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2019 (%)
FIGURE 11 CEREBRAL OXIMETER GLOBAL MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2019 (%)
FIGURE 12 PULSE OXIMETER GLOBAL MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2019 (%)
FIGURE 13 FINGERTIP GLOBAL MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2019 (%)
FIGURE 14 HANDHELD GLOBAL MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2019 (%)
FIGURE 15 TABLETOP GLOBAL MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2019 (%)
FIGURE 16 OTHERS GLOBAL MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2019 (%)
FIGURE 17 ADULT V/S NEONATAL/PEDIATRIC CEREBRAL AND PULSE OXIMETER GLOBAL MARKET SHARE, 2019 (%)
FIGURE 18 GLOBAL CEREBRAL OXIMETER UNITS SOLD AND INSTALLED BASE, (2019)
FIGURE 19 GLOBAL CEREBRAL OXIMETER UNITS SOLD AND INSTALLED BASE, BY END-USER, (2019)
FIGURE 20 GLOBAL TABLETOP PULSE OXIMETER MONITORS NUMBER OF UNITS SOLD AND INSTALLED BASE, IN HOSPITALS(2019)
FIGURE 21 GLOBAL HANDHELD PULSE OXIMETER MONITORS NUMBER OF UNITS SOLD AND INSTALLED BASE, IN HOSPITALS(2019)
FIGURE 22 GLOBAL FINGERTIP PULSE OXIMETER, NUMBER OF UNITS SOLD AND INSTALLED BASE, BY REGION (2019)
FIGURE 23 GLOBAL WRIST PULSE OXIMETER, NUMBER OF UNITS SOLD AND INSTALLED BASE, BY REGION (2019)
FIGURE 24 GLOBAL MRI PULSE OXIMETER, NUMBER OF UNITS SOLD AND INSTALLED BASE, BY REGION (2019)
FIGURE 25 GLOBAL PULSE OXIMETER SENSORS, NUMBER OF UNITS SOLD AND INSTALLED BASE, BY REGION (2019)
FIGURE 26 TABLETOP PULSE OXIMETER MONITORS, NUMBER OF UNITS SOLD AND INSTALLED BASE, BY END-USER (2019)
FIGURE 27 HANDHELD PULSE OXIMETER MONITORS, NUMBER OF UNITS SOLD AND INSTALLED BASE, BY REGION (2019)
FIGURE 28 FINGERTIP PULSE OXIMETER NUMBER OF UNITS SOLD AND INSTALLED BASE, BY END-USER (2019)
FIGURE 29 WRIST PULSE OXIMETER NUMBER OF UNITS SOLD AND INSTALLED BASE, BY REGION (2019)
FIGURE 30 CEREBRAL AND PULSE OXIMETER GLOBAL MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 31 CEREBRAL OXIMETER GLOBAL MARKET SHARE, BY PRODUCT TYPE (2019 V/S 2026) (%)
FIGURE 32 CEREBRAL OXIMETER SENSORS GLOBAL MARKET SHARE, BY PRODUCT TYPE (2019 V/S 2026) (%)
FIGURE 33 PULSE OXIMETER GLOBAL MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 34 FINGERTIP PULSE OXIMETER GLOBAL MARKET SHARE, BY REGION (2019 V/S 2026) (%)
FIGURE 35 PULSE OXIMETER GLOBAL MARKET SHARE, BY PRODUCT TYPE (2019 V/S 2026) (%)
FIGURE 36 PULSE OXIMETER SENSORS GLOBAL MARKET SHARE, BY PRODUCT TYPE (2019 V/S 2026) (%)
FIGURE 37 CEREBRAL AND PULSE OXIMETER GLOBAL MARKET SHARE, BY APPLICATION (2019 V/S 2026) (%)
FIGURE 38 CEREBRAL AND PULSE OXIMETER GLOBAL MARKET SHARE, BY END-USERS (2019 V/S 2026) (%)
FIGURE 39 HOSPITAL AND ICU GLOBAL MARKET REVENUE BY SITE OF CARE (2019) ($MN)
FIGURE 40 GENERAL WARDS GLOBAL MARKET SHARE, BY REGION (2019 V/S 2026) (%)
FIGURE 41 CEREBRAL AND PULSE OXIMETER GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN), CAGR (%)
FIGURE 42 CEREBRAL AND PULSE OXIMETER GLOBAL MARKET SHARE BY REGION AND MARKET REVENUE BY COUNTRY, (2019) (%) ($MN)
FIGURE 43 NORTH AMERICA CEREBRAL AND PULSE OXIMETER MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 44 NORTH AMERICA CEREBRAL OXIMETER MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 45 NORTH AMERICA CEREBRAL OXIMETER SENSORS MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 46 NORTH AMERICA PULSE OXIMETER MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 47 NORTH AMERICA PULSE OXIMETER MARKET SHARE, BY PRODUCT TYPE (2019 V/S 2026) (%)
FIGURE 48 NORTH AMERICA PULSE OXIMETER SENSORS MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 49 NORTH AMERICA CEREBRAL AND PULSE OXIMETER MARKET SHARE, BY APPLICATION (2019 V/S 2026) (%)
FIGURE 50 NORTH AMERICA CEREBRAL AND PULSE OXIMETER MARKET SHARE, BY END-USER (2019 V/S 2026) (%)
FIGURE 51 NORTH AMERICA HOSPITAL AND ICU MARKET REVENUE, BY SITE OF CARE (2019) ($MN)
FIGURE 52 NORTH AMERICA CEREBRAL AND PULSE OXIMETER MARKET SHARE, BY COUNTRY (2019 V/S 2026) (%)
FIGURE 53 NORTH AMERICA CEREBRAL OXIMETER MONITORS MARKET PENETRATION, (2019)
FIGURE 54 NORTH AMERICA TABLETOP PULSE OXIMETER MONITORS NUMBER OF UNITS SOLD AND INSTALLED BASE, IN HOSPITALS(2019)
FIGURE 55 NORTH AMERICA HANDHELD PULSE OXIMETER MONITORS NUMBER OF UNITS SOLD AND INSTALLED BASE, IN HOSPITALS(2019)
FIGURE 56 U.S. CEREBRAL AND PULSE OXIMETER MARKET REVENUE, BY PRODUCT, APPLICATION AND END-USER (2019 V/S 2026) ($MN)
FIGURE 57 REST OF N.A. CEREBRAL AND PULSE OXIMETER MARKET REVENUE, BY PRODUCT, APPLICATION AND END-USER (2019 V/S 2026) ($MN)
FIGURE 58 EUROPE CEREBRAL AND PULSE OXIMETER MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 59 EUROPE CEREBRAL OXIMETER MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 60 EUROPE CEREBRAL OXIMETER SENSORS MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 61 EUROPE PULSE OXIMETER MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 62 EUROPE PULSE OXIMETER MARKET SHARE, BY PRODUCT TYPE (2019 V/S 2026) (%)
FIGURE 63 EUROPE PULSE OXIMETER SENSORS MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 64 EUROPE CEREBRAL AND PULSE OXIMETER MARKET SHARE, BY APPLICATION (2019 V/S 2026) (%)
FIGURE 65 EUROPE CEREBRAL AND PULSE OXIMETER MARKET SHARE, BY END-USER (2019 V/S 2026) (%)
FIGURE 66 EUROPE HOSPITAL AND ICU MARKET REVENUE, BY SITE OF CARE (2019) ($MN)
FIGURE 67 EUROPE CEREBRAL AND PULSE OXIMETER MARKET SHARE, BY COUNTRY (2019 V/S 2026) (%)
FIGURE 68 EUROPE CEREBRAL OXIMETER MONITORS MARKET PENETRATION, (2019)
FIGURE 69 EUROPE TABLETOP PULSE OXIMETER MONITORS, NUMBER OF UNITS SOLD AND INSTALLED BASE, IN HOSPITALS(2019)
FIGURE 70 EUROPE HANDHELD PULSE OXIMETER MONITORS NUMBER OF UNITS SOLD AND INSTALLED BASE, IN HOSPITALS(2019)
FIGURE 71 GERMANY CEREBRAL AND PULSE OXIMETER MARKET REVENUE, BY PRODUCT, APPLICATION AND END-USER (2019 V/S 2026) ($MN)
FIGURE 72 FRANCE CEREBRAL AND PULSE OXIMETER MARKET REVENUE, BY PRODUCT, APPLICATION AND END-USER (2019 V/S 2026) ($MN)
FIGURE 73 ITALY CEREBRAL AND PULSE OXIMETER MARKET REVENUE, BY PRODUCT, APPLICATION AND END-USER (2019 V/S 2026) ($MN)
FIGURE 74 REST OF E.U. CEREBRAL AND PULSE OXIMETER MARKET REVENUE, BY PRODUCT, APPLICATION AND END-USER (2019 V/S 2026) ($MN)
FIGURE 75 APAC CEREBRAL AND PULSE OXIMETER MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 76 APAC CEREBRAL OXIMETER MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 77 APAC CEREBRAL OXIMETER SENSORS MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 78 APAC CEREBRAL AND PULSE OXIMETER MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 79 APAC CEREBRAL AND PULSE OXIMETER MARKET SHARE, BY PRODUCT TYPE (2019 V/S 2026) (%)
FIGURE 80 APAC PULSE OXIMETER SENSORS MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 81 APAC CEREBRAL AND PULSE OXIMETER MARKET SHARE, BY APPLICATION (2019 V/S 2026) (%)
FIGURE 82 APAC CEREBRAL AND PULSE OXIMETER MARKET SHARE, BY END-USER (2019 V/S 2026) (%)
FIGURE 83 APAC HOSPITAL AND ICU MARKET REVENUE, BY SITE OF CARE (2019) ($MN)
FIGURE 84 APAC CEREBRAL AND PULSE OXIMETER MARKET SHARE, BY COUNTRY (2019 V/S 2026) (%)
FIGURE 85 APAC CEREBRAL OXIMETER MONITORS MARKET PENETRATION, (2019)
FIGURE 86 APAC TABLETOP PULSE OXIMETER MONITORS NUMBER OF UNITS SOLD AND INSTALLED BASE, IN HOSPITALS(2019)
FIGURE 87 APAC HANDHELD PULSE OXIMETER MONITORS NUMBER OF UNITS SOLD AND INSTALLED BASE, IN HOSPITALS(2019)
FIGURE 88 JAPAN CEREBRAL AND PULSE OXIMETER MARKET REVENUE, BY PRODUCT, APPLICATION AND END-USER (2019 V/S 2026) ($MN)
FIGURE 89 CHINA CEREBRAL AND PULSE OXIMETER MARKET REVENUE, BY PRODUCT, APPLICATION AND END-USER (2019 V/S 2026) ($MN)
FIGURE 90 INDIA CEREBRAL AND PULSE OXIMETER MARKET REVENUE, BY PRODUCT, APPLICATION AND END-USER (2019 V/S 2026) ($MN)
FIGURE 91 REST OF APAC CEREBRAL AND PULSE OXIMETER MARKET REVENUE, BY PRODUCT, APPLICATION AND END-USER (2019 V/S 2026) ($MN)
FIGURE 92 ROW CEREBRAL AND PULSE OXIMETER MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 93 ROW CEREBRAL OXIMETER MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 94 ROW CEREBRAL OXIMETER SENSORS MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 95 ROW PULSE OXIMETER MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 96 ROW PULSE OXIMETER MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 97 ROW PULSE OXIMETER SENSORS MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 98 ROW CEREBRAL AND PULSE OXIMETER MARKET SHARE, BY APPLICATION (2019 V/S 2026) (%)
FIGURE 99 ROW CEREBRAL AND PULSE OXIMETER MARKET SHARE, BY END-USER (2019 V/S 2026) (%)
FIGURE 100 ROW HOSPITAL AND ICU MARKET REVENUE, BY SITE OF CARE (2019) ($MN)
FIGURE 101 ROW CEREBRAL AND PULSE OXIMETER MARKET SHARE, BY COUNTRY (2019 V/S 2026) (%)
FIGURE 102 ROW CEREBRAL OXIMETER MONITORS MARKET PENETRATION, (2019)
FIGURE 103 ROW TABLETOP PULSE OXIMETER MONITORS NUMBER OF UNITS SOLD AND INSTALLED BASE, IN HOSPITALS(2019)
FIGURE 104 ROW HANDHELD PULSE OXIMETER MONITORS NUMBER OF UNITS SOLD AND INSTALLED BASE, IN HOSPITALS(2019)
FIGURE 105 BRZIL CEREBRAL AND PULSE OXIMETER MARKET REVENUE, BY PRODUCT, APPLICATION AND END-USER (2019 V/S 2026) ($MN)
FIGURE 106 REST OF LATAM CEREBRAL AND PULSE OXIMETER MARKET REVENUE, BY PRODUCT, APPLICATION AND END-USER (2019 V/S 2026) ($MN)
FIGURE 107 MIDDLE EAST AND OTHERS CEREBRAL AND PULSE OXIMETER MARKET REVENUE, BY PRODUCT, APPLICATION AND END-USER (2019 V/S 2026) ($MN)
FIGURE 108 KEY GROWTH STRATEGIES (2018-2019)
FIGURE 109 SWOT: EDWARDS LIFESCIENCES INC.
FIGURE 110 SWOT: GE HEALTHCARE
FIGURE 111 SWOT: HEAL FORCE BIO-MEDITECH LIMITED.
FIGURE 112 SWOT: KONINKLIJKE PHILIPS N.V.
FIGURE 113 SWOT: MASIMO CORPORATION
FIGURE 114 SWOT: MEDTRONIC PLC
FIGURE 115 SWOT: NIHON KOHDEN.
FIGURE 116 SWOT: NONIN MEDICAL INC.
FIGURE 117 SWOT: ROSSMAX INTERNATIONAL LTD.
FIGURE 118 SWOT: SHENZHEN MINDRAY BIO-MEDICAL ELECTRONIC CO., LTD.
FIGURE 119 SWOT: SMITHS MEDICAL
FIGURE 1 CEREBRAL AND PULSE OXIMETER GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
FIGURE 2 RESEARCH METHODOLOGY: CEREBRAL AND PULSE OXIMETER GLOBAL MARKET
FIGURE 3 CEREBRAL AND PULSE OXIMETER GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
FIGURE 4 CEREBRAL AND PULSE OXIMETER GLOBAL MARKET: FORECASTING MODEL
FIGURE 5 CEREBRAL AND PULSE OXIMETER GLOBAL MARKET: MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 6 CEREBRAL AND PULSE OXIMETER GLOBAL MARKET SEGMENTATION
FIGURE 7 MARKET DYNAMICS
FIGURE 8 CEREBRAL AND PULSE OXIMETER GLOBAL MARKET: PORTER’S ANALYSIS
FIGURE 9 CEREBRAL AND PULSE OXIMETER GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 10 CEREBRAL AND PULSE OXIMETER GLOBAL MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2019 (%)
FIGURE 11 CEREBRAL OXIMETER GLOBAL MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2019 (%)
FIGURE 12 PULSE OXIMETER GLOBAL MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2019 (%)
FIGURE 13 FINGERTIP GLOBAL MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2019 (%)
FIGURE 14 HANDHELD GLOBAL MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2019 (%)
FIGURE 15 TABLETOP GLOBAL MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2019 (%)
FIGURE 16 OTHERS GLOBAL MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2019 (%)
FIGURE 17 ADULT V/S NEONATAL/PEDIATRIC CEREBRAL AND PULSE OXIMETER GLOBAL MARKET SHARE, 2019 (%)
FIGURE 18 GLOBAL CEREBRAL OXIMETER UNITS SOLD AND INSTALLED BASE, (2019)
FIGURE 19 GLOBAL CEREBRAL OXIMETER UNITS SOLD AND INSTALLED BASE, BY END-USER, (2019)
FIGURE 20 GLOBAL TABLETOP PULSE OXIMETER MONITORS NUMBER OF UNITS SOLD AND INSTALLED BASE, IN HOSPITALS(2019)
FIGURE 21 GLOBAL HANDHELD PULSE OXIMETER MONITORS NUMBER OF UNITS SOLD AND INSTALLED BASE, IN HOSPITALS(2019)
FIGURE 22 GLOBAL FINGERTIP PULSE OXIMETER, NUMBER OF UNITS SOLD AND INSTALLED BASE, BY REGION (2019)
FIGURE 23 GLOBAL WRIST PULSE OXIMETER, NUMBER OF UNITS SOLD AND INSTALLED BASE, BY REGION (2019)
FIGURE 24 GLOBAL MRI PULSE OXIMETER, NUMBER OF UNITS SOLD AND INSTALLED BASE, BY REGION (2019)
FIGURE 25 GLOBAL PULSE OXIMETER SENSORS, NUMBER OF UNITS SOLD AND INSTALLED BASE, BY REGION (2019)
FIGURE 26 TABLETOP PULSE OXIMETER MONITORS, NUMBER OF UNITS SOLD AND INSTALLED BASE, BY END-USER (2019)
FIGURE 27 HANDHELD PULSE OXIMETER MONITORS, NUMBER OF UNITS SOLD AND INSTALLED BASE, BY REGION (2019)
FIGURE 28 FINGERTIP PULSE OXIMETER NUMBER OF UNITS SOLD AND INSTALLED BASE, BY END-USER (2019)
FIGURE 29 WRIST PULSE OXIMETER NUMBER OF UNITS SOLD AND INSTALLED BASE, BY REGION (2019)
FIGURE 30 CEREBRAL AND PULSE OXIMETER GLOBAL MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 31 CEREBRAL OXIMETER GLOBAL MARKET SHARE, BY PRODUCT TYPE (2019 V/S 2026) (%)
FIGURE 32 CEREBRAL OXIMETER SENSORS GLOBAL MARKET SHARE, BY PRODUCT TYPE (2019 V/S 2026) (%)
FIGURE 33 PULSE OXIMETER GLOBAL MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 34 FINGERTIP PULSE OXIMETER GLOBAL MARKET SHARE, BY REGION (2019 V/S 2026) (%)
FIGURE 35 PULSE OXIMETER GLOBAL MARKET SHARE, BY PRODUCT TYPE (2019 V/S 2026) (%)
FIGURE 36 PULSE OXIMETER SENSORS GLOBAL MARKET SHARE, BY PRODUCT TYPE (2019 V/S 2026) (%)
FIGURE 37 CEREBRAL AND PULSE OXIMETER GLOBAL MARKET SHARE, BY APPLICATION (2019 V/S 2026) (%)
FIGURE 38 CEREBRAL AND PULSE OXIMETER GLOBAL MARKET SHARE, BY END-USERS (2019 V/S 2026) (%)
FIGURE 39 HOSPITAL AND ICU GLOBAL MARKET REVENUE BY SITE OF CARE (2019) ($MN)
FIGURE 40 GENERAL WARDS GLOBAL MARKET SHARE, BY REGION (2019 V/S 2026) (%)
FIGURE 41 CEREBRAL AND PULSE OXIMETER GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN), CAGR (%)
FIGURE 42 CEREBRAL AND PULSE OXIMETER GLOBAL MARKET SHARE BY REGION AND MARKET REVENUE BY COUNTRY, (2019) (%) ($MN)
FIGURE 43 NORTH AMERICA CEREBRAL AND PULSE OXIMETER MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 44 NORTH AMERICA CEREBRAL OXIMETER MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 45 NORTH AMERICA CEREBRAL OXIMETER SENSORS MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 46 NORTH AMERICA PULSE OXIMETER MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 47 NORTH AMERICA PULSE OXIMETER MARKET SHARE, BY PRODUCT TYPE (2019 V/S 2026) (%)
FIGURE 48 NORTH AMERICA PULSE OXIMETER SENSORS MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 49 NORTH AMERICA CEREBRAL AND PULSE OXIMETER MARKET SHARE, BY APPLICATION (2019 V/S 2026) (%)
FIGURE 50 NORTH AMERICA CEREBRAL AND PULSE OXIMETER MARKET SHARE, BY END-USER (2019 V/S 2026) (%)
FIGURE 51 NORTH AMERICA HOSPITAL AND ICU MARKET REVENUE, BY SITE OF CARE (2019) ($MN)
FIGURE 52 NORTH AMERICA CEREBRAL AND PULSE OXIMETER MARKET SHARE, BY COUNTRY (2019 V/S 2026) (%)
FIGURE 53 NORTH AMERICA CEREBRAL OXIMETER MONITORS MARKET PENETRATION, (2019)
FIGURE 54 NORTH AMERICA TABLETOP PULSE OXIMETER MONITORS NUMBER OF UNITS SOLD AND INSTALLED BASE, IN HOSPITALS(2019)
FIGURE 55 NORTH AMERICA HANDHELD PULSE OXIMETER MONITORS NUMBER OF UNITS SOLD AND INSTALLED BASE, IN HOSPITALS(2019)
FIGURE 56 U.S. CEREBRAL AND PULSE OXIMETER MARKET REVENUE, BY PRODUCT, APPLICATION AND END-USER (2019 V/S 2026) ($MN)
FIGURE 57 REST OF N.A. CEREBRAL AND PULSE OXIMETER MARKET REVENUE, BY PRODUCT, APPLICATION AND END-USER (2019 V/S 2026) ($MN)
FIGURE 58 EUROPE CEREBRAL AND PULSE OXIMETER MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 59 EUROPE CEREBRAL OXIMETER MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 60 EUROPE CEREBRAL OXIMETER SENSORS MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 61 EUROPE PULSE OXIMETER MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 62 EUROPE PULSE OXIMETER MARKET SHARE, BY PRODUCT TYPE (2019 V/S 2026) (%)
FIGURE 63 EUROPE PULSE OXIMETER SENSORS MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 64 EUROPE CEREBRAL AND PULSE OXIMETER MARKET SHARE, BY APPLICATION (2019 V/S 2026) (%)
FIGURE 65 EUROPE CEREBRAL AND PULSE OXIMETER MARKET SHARE, BY END-USER (2019 V/S 2026) (%)
FIGURE 66 EUROPE HOSPITAL AND ICU MARKET REVENUE, BY SITE OF CARE (2019) ($MN)
FIGURE 67 EUROPE CEREBRAL AND PULSE OXIMETER MARKET SHARE, BY COUNTRY (2019 V/S 2026) (%)
FIGURE 68 EUROPE CEREBRAL OXIMETER MONITORS MARKET PENETRATION, (2019)
FIGURE 69 EUROPE TABLETOP PULSE OXIMETER MONITORS, NUMBER OF UNITS SOLD AND INSTALLED BASE, IN HOSPITALS(2019)
FIGURE 70 EUROPE HANDHELD PULSE OXIMETER MONITORS NUMBER OF UNITS SOLD AND INSTALLED BASE, IN HOSPITALS(2019)
FIGURE 71 GERMANY CEREBRAL AND PULSE OXIMETER MARKET REVENUE, BY PRODUCT, APPLICATION AND END-USER (2019 V/S 2026) ($MN)
FIGURE 72 FRANCE CEREBRAL AND PULSE OXIMETER MARKET REVENUE, BY PRODUCT, APPLICATION AND END-USER (2019 V/S 2026) ($MN)
FIGURE 73 ITALY CEREBRAL AND PULSE OXIMETER MARKET REVENUE, BY PRODUCT, APPLICATION AND END-USER (2019 V/S 2026) ($MN)
FIGURE 74 REST OF E.U. CEREBRAL AND PULSE OXIMETER MARKET REVENUE, BY PRODUCT, APPLICATION AND END-USER (2019 V/S 2026) ($MN)
FIGURE 75 APAC CEREBRAL AND PULSE OXIMETER MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 76 APAC CEREBRAL OXIMETER MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 77 APAC CEREBRAL OXIMETER SENSORS MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 78 APAC CEREBRAL AND PULSE OXIMETER MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 79 APAC CEREBRAL AND PULSE OXIMETER MARKET SHARE, BY PRODUCT TYPE (2019 V/S 2026) (%)
FIGURE 80 APAC PULSE OXIMETER SENSORS MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 81 APAC CEREBRAL AND PULSE OXIMETER MARKET SHARE, BY APPLICATION (2019 V/S 2026) (%)
FIGURE 82 APAC CEREBRAL AND PULSE OXIMETER MARKET SHARE, BY END-USER (2019 V/S 2026) (%)
FIGURE 83 APAC HOSPITAL AND ICU MARKET REVENUE, BY SITE OF CARE (2019) ($MN)
FIGURE 84 APAC CEREBRAL AND PULSE OXIMETER MARKET SHARE, BY COUNTRY (2019 V/S 2026) (%)
FIGURE 85 APAC CEREBRAL OXIMETER MONITORS MARKET PENETRATION, (2019)
FIGURE 86 APAC TABLETOP PULSE OXIMETER MONITORS NUMBER OF UNITS SOLD AND INSTALLED BASE, IN HOSPITALS(2019)
FIGURE 87 APAC HANDHELD PULSE OXIMETER MONITORS NUMBER OF UNITS SOLD AND INSTALLED BASE, IN HOSPITALS(2019)
FIGURE 88 JAPAN CEREBRAL AND PULSE OXIMETER MARKET REVENUE, BY PRODUCT, APPLICATION AND END-USER (2019 V/S 2026) ($MN)
FIGURE 89 CHINA CEREBRAL AND PULSE OXIMETER MARKET REVENUE, BY PRODUCT, APPLICATION AND END-USER (2019 V/S 2026) ($MN)
FIGURE 90 INDIA CEREBRAL AND PULSE OXIMETER MARKET REVENUE, BY PRODUCT, APPLICATION AND END-USER (2019 V/S 2026) ($MN)
FIGURE 91 REST OF APAC CEREBRAL AND PULSE OXIMETER MARKET REVENUE, BY PRODUCT, APPLICATION AND END-USER (2019 V/S 2026) ($MN)
FIGURE 92 ROW CEREBRAL AND PULSE OXIMETER MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 93 ROW CEREBRAL OXIMETER MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 94 ROW CEREBRAL OXIMETER SENSORS MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 95 ROW PULSE OXIMETER MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 96 ROW PULSE OXIMETER MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 97 ROW PULSE OXIMETER SENSORS MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 98 ROW CEREBRAL AND PULSE OXIMETER MARKET SHARE, BY APPLICATION (2019 V/S 2026) (%)
FIGURE 99 ROW CEREBRAL AND PULSE OXIMETER MARKET SHARE, BY END-USER (2019 V/S 2026) (%)
FIGURE 100 ROW HOSPITAL AND ICU MARKET REVENUE, BY SITE OF CARE (2019) ($MN)
FIGURE 101 ROW CEREBRAL AND PULSE OXIMETER MARKET SHARE, BY COUNTRY (2019 V/S 2026) (%)
FIGURE 102 ROW CEREBRAL OXIMETER MONITORS MARKET PENETRATION, (2019)
FIGURE 103 ROW TABLETOP PULSE OXIMETER MONITORS NUMBER OF UNITS SOLD AND INSTALLED BASE, IN HOSPITALS(2019)
FIGURE 104 ROW HANDHELD PULSE OXIMETER MONITORS NUMBER OF UNITS SOLD AND INSTALLED BASE, IN HOSPITALS(2019)
FIGURE 105 BRZIL CEREBRAL AND PULSE OXIMETER MARKET REVENUE, BY PRODUCT, APPLICATION AND END-USER (2019 V/S 2026) ($MN)
FIGURE 106 REST OF LATAM CEREBRAL AND PULSE OXIMETER MARKET REVENUE, BY PRODUCT, APPLICATION AND END-USER (2019 V/S 2026) ($MN)
FIGURE 107 MIDDLE EAST AND OTHERS CEREBRAL AND PULSE OXIMETER MARKET REVENUE, BY PRODUCT, APPLICATION AND END-USER (2019 V/S 2026) ($MN)
FIGURE 108 KEY GROWTH STRATEGIES (2018-2019)
FIGURE 109 SWOT: EDWARDS LIFESCIENCES INC.
FIGURE 110 SWOT: GE HEALTHCARE
FIGURE 111 SWOT: HEAL FORCE BIO-MEDITECH LIMITED.
FIGURE 112 SWOT: KONINKLIJKE PHILIPS N.V.
FIGURE 113 SWOT: MASIMO CORPORATION
FIGURE 114 SWOT: MEDTRONIC PLC
FIGURE 115 SWOT: NIHON KOHDEN.
FIGURE 116 SWOT: NONIN MEDICAL INC.
FIGURE 117 SWOT: ROSSMAX INTERNATIONAL LTD.
FIGURE 118 SWOT: SHENZHEN MINDRAY BIO-MEDICAL ELECTRONIC CO., LTD.
FIGURE 119 SWOT: SMITHS MEDICAL
